MarketBeat
08 Aug 2026, 07:04 UTC · 2h ago
Evolent Health Q2 Earnings Call Highlights
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
MarketBeat
08 Aug 2026, 07:04 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Evolent Health announced a new oncology Performance Suite agreement expected to generate approximately $300 million in annualized revenue by December 2026. — A substantial increase in annualized revenue from a single new contract provides a strong growth catalyst and validates the scalability of the Performance Suite.
+0.80The company raised its full-year revenue guidance to a range of $2.6 billion to $2.7 billion, up from $2.4 billion to $2.6 billion. — Raising top-line guidance indicates strong operational momentum and confidence in near-term growth trajectories.
+0.60Evolent expects revenue growth of more than 25% in 2027 with a midpoint adjusted EBITDA outlook at or above $150 million. — Providing specific, aggressive long-term growth targets helps investors model future valuation and suggests a path to increased profitability.
+0.50Continue reading
6 related stories
Top 3 movers · tap to explore
The second-quarter medical expense ratio (MER) rose to 95% from 93% in the first quarter, primarily due to the Highmark launch and higher reserves. — While management framed the increase as expected, a rising MER generally indicates higher costs or risk, which can compress margins.
-0.30Evolent narrowed its full-year adjusted EBITDA guidance to $120 million to $135 million, lowering the previous upper bound of $140 million. — Reducing the ceiling of EBITDA guidance suggests a slight moderation in profitability expectations despite revenue growth.
-0.20Which stocks this story touches
Strong revenue growth, raised full-year guidance, and a new oncology agreement expected to generate $300 million in annualized revenue.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
MarketBeat
1h ago
